Bibliografia

1. Maffulli N, Wong J. Rupture of the Achilles and patellar tendons. Clin Sports Med 2003 Oct; 22(4): 761-76.

2. Khoschnau S, Melhus H, Jacobson A, et al. Type I collagen alpha1 Sp1 polymorphism and the risk of cruciate ligament ruptures or shoulder dislocations. Am J Sports Med 2008 Dec; 36(12): 2432-6.

3. Järvinen TA, Kannus P, Järvinen TL, et al. Tenascin-C in the pathobiology and healing process of musculoskeletal tissue injury. Scand J Med Sci Sports 2000 Dec; 10(6): 376-82.

4. Franceschi F, Longo UG, Ruzzini L, Rizzello G, Maffulli N, Denaro V. No advantages in repairing a type II superior labrum anterior and posterior (SLAP) lesion when associated with rotator cuff repair in patients over age 50: a randomized controlled trial. Am J Sports Med 2008; 36: 247-53.

5. Maffulli N, Wong J. Rupture of the Achilles and patellar tendons. Clin Sports Med 2003 Oct; 22(4): 761-76.

6. Józsa L, Kvist M, Bálint BJ, et al. The role of recreational sport activity in Achilles tendon rupture. A clinical, pathoanatomical, and sociological study of 292 cases. Am J Sports Med 1989 May-Jun; 17(3): 338-43.

7. September AV, Schwellnus MP, Collins M. Tendon and ligament injuries: the genetic component. Br J Sports Med 2007; 41(4): 241-6.

8. Mokone GG, Gajjar M, September AV, et . The guanine-thymine dinucleotide repeat polymorphism within the tenascin-C gene is associated with achilles tendon injuries. Am J Sports Med 2005 Jul; 33(7): 1016-21.

9. Harvie P, Ostlere SJ, Teh J, et al. Genetic influences in the aetiology of tears of the rotator cuff. Sibling risk of a full-thickness tear. J Bone Joint Surg Br 2004 Jul; 86(5): 696-700.

10. Lippi G, Longo UG, Maffulli N. Genetics and sports. Br Med Bull 2010; 93: 27-47.

11. Bennett EP, Steffensen R, Clausen H et al. Genomic cloning of the human histo-blood group ABO locus. Biochem Biophys Res Commun 1995; 206: 18-25.

12. September AV, Cook J, Handley CJ, et al. Variants within the COL5A1 gene are associated with Achilles tendinopathy in two populations. Br J Sports Med 2009 May; 43(5): 357-65.

13. Raleigh SM, van der Merwe L, et al. Variants within the MMP3 gene are associated with Achilles tendinopathy: possible interaction with the COL5A1 gene. Br J Sports Med 2009 Jul; 43(7): 514-20.

14. Posthumus M, September AV, O’Cuinneagain D, et al. The COL5A1 gene is associated with increased risk of anterior cruciate ligament ruptures in female participants. Am J Sports Med 2009B; 37(11): 2234-40.

15. Posthumus M, September AV, Schwellnus MP, Collins M. Investigation of the Sp1-binding site polymorphism within the COL1A1 gene in participants with Achilles tendon injuries and controls. J Sci Med Sport 2009 Jan; 12(1): 184-9.

16. Mokone GG, Schwellnus MP, Noakes TD, Collins M. The COL5A1 gene and Achilles tendon pathology. Scand J Med Sci Sports 2006 Feb; 16(1): 19-26.

17. Mackie EJ. Molecules in focus: tenascin-C. Int J Biochem Cell Biol 1997; 29: 1133-7.

18. Riley GP. Gene expression and matrix turnover in overused and damaged tendons. Scand J Med Sci Sports 2005 Aug; 15(4): 241-51.

19. Longo UG, Fazio V, Poeta ML, et al. Bilateral consecutive rupture of the quadriceps tendon in a man with BstUI polymorphism of the COL5A1 gene. Knee Surg Sports Traumatol Arthrosc 2010 Apr; 18(4): 514-8.

20. Brown JC, Miller CJ, Posthumus M, Schwellnus MP, Collins M. The COL5A1 Gene, Ultra-Marathon Running Performance, and Range of Motion. Int J Sports Physiol Perform 2011B Dec; 6(4): 485-96.

21. Brown JC, Miller CJ, Schwellnus MP, Collins M. Range of motion measurements diverge with increasing age for COL5A1 genotypes. Scand J Med Sci Sports 2011A Dec; 21(6): e266-72.

22. Magra M, Maffulli N. Matrix metalloproteases: a role in overuse tendinopathies. Br J Sports Med 2005 Nov; 39(11): 789-91.

23. Henney AM, Wakeley PR, Davies MJ et al. Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. Proc Natl Acad Sci USA 1991; 88: 8154-8.

24. Cotignola J, Roy P, Patel A, et al. Functional polymorphisms in the promoter regions of MMP2 and MMP3 are not associated with melanoma progression. J Negat Results Biomed 2007 Oct 24; 6: 9.

25. Nan H, Niu T, Hunter DJ, Han J. Missense polymorphisms in matrix metalloproteinase genes and skin cancer risk. Cancer Epidemiol Biomarkers Prev 2008 Dec; 17(12): 3551-7.

26. Ntayi C, Hornebeck W, Bernard P. Involvement of matrix metalloproteinases (MMPs) in cutaneous melanoma progression. Pathol Biol (Paris) 2004 Apr; 52(3): 154-9.

27. Vasku V, Bienertova Vasku J, Slonková V, Kanková K, Vasku A. Matrix metalloproteinase-2 promoter variability in psoriasis. Arch Dermatol Res 2009 Jul; 301(6): 467-73.

28. Shibata N, Ohnuma T, Higashi S, et al. Genetic association between matrix metalloproteinase MMP-9 and MMP-3 polymorphisms and Japanese sporadic Alzheimer’s disease. Neurobiol Aging 2005 Jul; 26(7): 1011-4.

29. Yoshiyama Y, Asahina M, Hattori T. Selective distribution of matrix metalloproteinase-3 (MMP-3) in Alzheimer’s disease brain. Acta Neuropathol (Berl) 2000; 99(2): 91-5.

30. Puthucheary Z, Skipworth JR, Rawal J, et al. Genetic influences in sport and physical performance. Sports Med 2011 Oct 1; 41(10): 845-59.

31. Corps AN et al. Increased expression of aggrecan and biglycan mRNA in Achilles tendinopathy. Rheumatology (Oxford) 2006; 45: 291-4.

32. Karousou E, Ronga M, Vigetti D, Passi A, Maffulli N. Collagens, proteoglycans, MMP-2, MMP-9 and TIMPs in human achilles tendon rupture. Clin Orthop Relat Res 2008 Jul; 466(7): 1577-82.

33. Jones GC, Corps AN, Pennington CJ, et al. Expression profiling of metalloproteinases and tissue inhibitors of metalloproteinases in normal and degenerate human achilles tendon. Arthritis Rheum 2006 Mar; 54(3): 832-42.

34. Karousou EG, Porta G, De Luca G, Passi A. Analysis of fluorophore-labelled hyaluronan and chondroitin sulfate disaccharides in biological samples. J Pharm Biomed Anal 2004; 34: 791-5.

35. Pufe T, Petersen WJ, Mentlein R et al. The role of vasculature and angiogenesis for the pathogenesis of degenerative tendons disease. Scand JMed Sci Sports 2005; 15(4): 211-22.

36. Lysholm J, Wiklander J. Injuries in runners. Am J Sports Med 1987; 15(2): 168-71.

37. Knobloch K, Yoon U, Vogt PM. Acute and overuse injuries correlated to hours of training in master running athletes. Foot Ankle Int 2008 Jul; 29(7): 671-6.

38. Yoshiyama Y, Sato H, Seiki M, et al. Expression of the membrane-type 3 matrix metalloproteinase (MT3-MMP) in human brain tissues. Acta Neuropathol (Berl) 1998; 96(4): 347-50.

39. Raleigh SM, van der Merwe L, Ribbans WJ, et al. Variants within the MMP3 gene are associated with Achilles tendinopathy: possible interaction with the COL5A1 gene. Br J Sports Med 2009 Jul; 43(7): 514-20.

40. Dunleavey L, Beyzade S, Ye S. Rapid genotype analysis of the stromelysin gene 5A/6A polymorphism. Atherosclerosis 2000 Aug; 151(2): 587-9.

41. Gnasso A, Motti C, Irace C, et al. Genetic variation in human stromelysin gene promoter and common carotid geometry in healthy male subjects. Arterioscler Thromb Vasc Biol 2000 Jun; 20(6): 1600-5.

42. Malila S, Yuktanandana P, Saowaprut S, Jiamjarasrangsi W, Honsawek S. Association between matrix metalloproteinase-3 polymorphism and anterior cruciate ligament ruptures. Genet Mol Res 2011 Oct 31; 10(4).

43. Posthumus M, September AV, Keegan M, et al. Genetic risk factors for anterior cruciate ligament ruptures: COL1A1 gene variant. Br J Sports Med 2009A; 43(5): 352-6.

44. Flynn RK, Pedersen CL, Birmingham TB, et al. The familial predisposition toward tearing the anterior cruciate ligament: a case–control study. Am J Sports Med 2005; 33: 23-8.

45. Dowdy PA, O’Driscoll SW. Shoulder instability. An analysis of family history. J Bone 1993.

46. Posthumus M, Collins M, van der Merwe L, et al. Matrix metalloproteinase genes on chromosome 11q22 and the risk of anterior cruciate ligament (ACL) rupture. Scand J Med Sci Sports 2011 [Epub ahead of print].

47. Mann V, Hobson EE, Li B, et al. A COL1A1 Sp1 binding site polymorphism predisposes to osteoporotic fracture by affecting bone density and quality. J Clin Invest 2001; 107: 899-907.

48. Lian K, Zmuda JM, Nevitt MC et al. Type I collagen alpha1 Sp1 transcription factor binding site polymorphism is associated with reduced risk of hip osteoarthritis defined by severe joint space narrowing in elderly women. Arthritis Rheum 2005; 52: 1431-6.

49. Speer G, Szenthe P, Kosa JP et al. Myocardial infarction is associated with Spl binding site polymorphism of collagen type 1A1 gene. Acta Cardiol 2006; 61: 321-5.

50. Tilkeridis C, Bei T, Garantziotis S, et al. Association of a COL1A1 polymorphism with lumbar disc disease in young military recruits. J Med Genet 2005; 42: e44.

51. Skorupski P, Krol J, Starega J, et al. An alpha-1 chain of type I collagen Sp1-binding site polymorphism in women suffering from stress urinary incontinence. Am J Obstet Gynecol 2006; 194: 346-50.

52. Tran BN, Nguyen ND, Center JR, Eisman JA, Nguyen TV. Enhancement of absolute fracture risk prognosis with genetic marker: the collagen I alpha 1 gene. Calcif Tissue Int 2009 Nov; 85(5): 379-88.

53. Grant SF, Reid DM, Blake G, et al. Reduced bone density and osteoporosis associated with a polymorphic Sp1 binding site in the collagen type I alpha 1 gene. Nat Genet 1996 Oct; 14(2): 203-5.

54. Bray MS, Hagberg JM, Pérusse L, et al. The human gene map for performance and health-related fitness phenotypes: the 2006-2007 update. Med Sci Sports Exerc 2009 Jan; 41(1): 35-73.

55. Brancaccio P, Maffulli N, Limongelli FM. Creatine kinase monitoring in sport medicine. Br Med Bull 2007; 81-82: 209-30.

56. Gennarelli M, Novelli G, Cobo A, Baiget M, Dallapiccola B. 3’ creatine kinase (M-type) polymorphisms linked to myotonic dystrophy in Italian and Spanish populations. Hum Genet. 1991 Oct; 87(6): 654-6.

57. Izzicupo P, Di Valerio V, D’Amico MA, et al. NAD(P)H oxidase and pro-inflammatory response during maximal exercise: role of C242T polymorphism of the P22PHOX subunit. Int J Immunopathol Pharmacol. 2010 Jan-Mar; 23(1): 203-11.

58. September AV, Nell EM, O’Connell K, et al. A pathway-based approach investigating the genes encoding interleukin-1ß, interleukin-6 and the interleukin-1 receptor antagonist provides new insight into the genetic susceptibility of Achilles tendinopathy. Br J Sp orts Med 2011 Oct; 45(13): 1040-7.